Project: Development of an epigenetics-based blood test to detect immunosuppression in sepsis patients

Acronym SEPSDIA (Reference Number: 11501)
Duration 01/01/2018
Project Topic The consortium will develop an innovative in vitro blood test to detect immunosuppression in sepsis patients. The test will be based on a promising set of epigenetic modification markers in immunologically relevant genes. In this project, these biomarkers will be developed into an IVD test that will be analytically and technically validated, and tested in a first clinical validation study. Directly after this project, the consortium will perform larger scale validation studies.
Network Eurostars 2
Call Eurostars Cut-Off 7

Project partner

Number Name Role Country
1 Diagenode S.A. Coordinator Belgium
2 Platomics GmbH Partner Austria
3 VARIONOSTIC GMBH Partner Germany
4 University of Heidelberg Partner Germany